South Africa city Oxford covid-19 vaccine infection South Africa city Oxford

South Africa suspends use of AstraZeneca's COVID-19 vaccine after it fails to clearly stop virus variant

Reading now: 790
www.sciencemag.org

Jon CohenScience's COVID-19 reporting is supported by the Heising-Simons Foundation.Another COVID-19 vaccine has run into trouble in South Africa, showing less protection there than elsewhere because a SARS-CoV-2 variant that can apparently dodge key antibodies has become widespread.

In the wake of the new finding, the country, which had pinned its pandemic hopes on this particular vaccine, halted an immunization campaign launched only last week.The stakes are high for the vaccine globally because its makers, AstraZeneca and the University of Oxford, hope it will be widely used in developing countries; they project they can produce 3 billion doses this year for around $3 each, far more product at a far less lower price than any other.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA